Stay updated on Filgotinib Combo in RA Patients Inadequate Response Clinical Trial
Sign up to get notified when there's something new on the Filgotinib Combo in RA Patients Inadequate Response Clinical Trial page.

Latest updates to the Filgotinib Combo in RA Patients Inadequate Response Clinical Trial page
- Check4 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedA site-wide NIH notice about terminology during a website transition appears above the 403 error page, and the displayed site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check32 days agoChange DetectedThe ClinicalTrials.gov study page continues to show a 403 Forbidden error, with the footer revision changing from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check46 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of showing the study details. This indicates the record is currently inaccessible to users.SummaryDifference18%

- Check53 days agoChange DetectedThe site's software version was updated from v3.6.6 to v3.7.0. This marks a new release of the underlying platform and does not alter page content.SummaryDifference0.0%

- Check60 days agoChange DetectedTel Litwinsky, Israel was added as a collaborator on the study page. Rheumatoid arthritis and the MedlinePlus Genetics related topic, along with the Qiryat Krinitzi, Israel location, were removed from the page.SummaryDifference0.1%

Stay in the know with updates to Filgotinib Combo in RA Patients Inadequate Response Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Filgotinib Combo in RA Patients Inadequate Response Clinical Trial page.